Edwards Lifesciences: Wells Fargo raises target price to $113 from $100
EW•Wells Fargo raised its target price for Edwards Lifesciences to $113 from $100.
Related News
Shift4 Payments Q3 gross profit $434 million
FOUR•
Virtu Financial Q3 revenue beats estimates on higher trading income
VIRT•
BMO raises Expedia Group target price to $300 from $285
EXPE•
1stDibs Q3 2026 net loss narrows 64% to $1.25 million
DIBS•
BMO cuts Boise Cascade to market perform from outperform, target price to $88 from $100
BCC•